Portfolio & Track Record

BIOIP CAPITAL PTE. LTD. manages a diversified and evolving portfolio spanning biotechnology, medical research, scientific infrastructure, real-world assets, and digital enablement platforms. Our portfolio reflects a multidisciplinary approach developed through years of operational involvement, advisory mandates, and strategic execution across complex sectors.

Capital Under Management

BioIP Capital currently manages approximately SGD 52 million in assets under management (AUM) across multiple structures and mandates. These assets are deployed through a combination of direct holdings, structured vehicles, joint ventures, and platform-based initiatives.

Capital under management includes:

Direct participation in research-driven ventures
Structured exposure via SPVs and venture joint structures
Real-world assets supporting scientific and operational ecosystems
Platform and infrastructure assets aligned with long-term innovation

Our capital is managed with a focus on durability, governance, and strategic alignment, rather than short-term transactional activity.

Portfolio Composition

Our portfolio is intentionally diversified across four interconnected pillars:

Biotechnology & Medical Research

Early-stage and growth-stage biotech initiatives
Translational and applied medical research programs
Immunotherapy and diagnostics-aligned projects
Botanical and traditional science research initiatives

These investments are often accompanied by operational support, infrastructure alignment, and strategic advisory, rather than passive capital allocation.

Scientific Infrastructure & Laboratories

Development, acquisition, and optimization of lab-ready facilities
Conversion of real estate and hospitality assets into research-supporting infrastructure
Strategic divestment of operational facilities to laboratories and research operators

BioIP Capital has been involved in end-to-end infrastructure cycles, including site identification, operational structuring, asset optimization, and exit execution.

Real-World Assets (RWA)

Real estate assets integrated into scientific and operational ecosystems
Hospitality properties repurposed or sold to support laboratory and research use cases
Selective exposure to mining operations linked to materials relevant to industrial and scientific supply chains

These assets are managed as functional components of broader platforms, not as isolated investments.

Partners

3

Venture Capital Partners

2

Cybersecurity Company Team

7

Marketing / Funding / Backed Partners

Digital & Tokenized Platforms

Exploration and structuring of tokenized real-world assets

Digital registry and ownership frameworks

Blockchain-enabled transparency layers supporting traditional structures

Tokenization initiatives are pursued selectively, with emphasis on governance, auditability, and operational relevance.

Previous Work & Engagements

BioIP Capital’s track record extends beyond current AUM and includes prior consulting, advisory, structuring, and operational roles across multiple jurisdictions.

Our previous work includes:

Advisory support for biotech and life-science ventures
Consulting mandates related to infrastructure development and optimization
Structuring of venture partnerships, SPVs, and joint initiatives
Strategic support for organizations preparing for institutional or market-facing engagement

Many of these engagements were executed confidentially, under non-disclosure, or as part of broader consortiums.

Consulting & Advisory Experience

In addition to direct investment activity, BioIP Capital has delivered strategic consulting and advisory services to founders, operators, and asset owners.

Areas of advisory experience include:

Venture and capital structure design
Research-to-commercialization strategy
Infrastructure and asset repositioning
Governance and operational readiness
Sponsor coordination and stakeholder alignment

These advisory roles often preceded or complemented capital deployment, enabling informed decision-making and risk mitigation.

Operational Roles & Executed Mandates

Beyond advisory work, BioIP Capital has participated in hands-on operational roles, including:

Oversight of lab development and facility operations
Coordination between researchers, operators, and capital partners
Execution of asset sales and strategic divestments
Management of platform-level initiatives across multiple stakeholders

This operational exposure informs our investment discipline and portfolio management approach.

Jobs Created & Ecosystem Impact

Through our portfolio companies, infrastructure assets, and consulting engagements, BioIP Capital has contributed to:

Job creation within laboratories, research teams, and operational entities
Development of research-supporting facilities and platforms
Enablement of cross-border collaboration between science, capital, and infrastructure

While we do not disclose employment figures publicly, our work consistently supports high-skill, research-driven, and operational roles.

Risk Management & Portfolio Governance

All portfolio activities are subject to:

Internal review and oversight
Legal and structural alignment
Partner and counterparty diligence
Ongoing monitoring and reassessment

This governance framework applies across investments, advisory mandates, and operational roles.

Portfolio Philosophy

Our portfolio reflects a clear philosophy:

Capital should support real innovation
Infrastructure must enable execution
Technology should improve transparency, not complexity
Long-term value is built through integration, not fragmentation

BioIP Capital’s portfolio is designed to evolve, adapt, and remain relevant as scientific, industrial, and technological landscapes change.

Looking Ahead

As BioIP Capital continues to grow its assets under management and expand its partnerships, our portfolio strategy remains focused on:

Responsible expansion
Strategic depth over breadth
Alignment between science, assets, and platforms

We continue to explore new opportunities that fit our core principles and strengthen our ecosystem.